Resultados de la búsqueda 41-50 of 8113 for targeted workouts

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... targeted therapies: targeted radiopharmaceutical therapy with 131I-MIBG or the ALK inhibitor, crizotinib. After enrollment, patients will receive one cycle ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... targeted therapies: targeted radiopharmaceutical therapy with 131I-MIBG or the ALK inhibitor, crizotinib. After enrollment, patients will receive one cycle ...

4. Hematología - Ensayos clínicos - Mayo Clinic

   In Part 1, different level of step-up doses are tested followed by the target dose of ABBV-383. In Part 2, the step-up dose identified in Part 1 will be used ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... targeted therapies: targeted radiopharmaceutical therapy with 131I-MIBG or the ALK inhibitor, crizotinib. After enrollment, patients will receive one cycle ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... targeted therapies: targeted radiopharmaceutical therapy with 131I-MIBG or the ALK inhibitor, crizotinib. After enrollment, patients will receive one cycle ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... targeted therapies: targeted radiopharmaceutical therapy with 131I-MIBG or the ALK inhibitor, crizotinib. After enrollment, patients will receive one cycle ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... targeted therapies: targeted radiopharmaceutical therapy with 131I-MIBG or the ALK inhibitor, crizotinib. After enrollment, patients will receive one cycle ...

9. Hematología - Ensayos clínicos - Mayo Clinic

   Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... targeted therapies: targeted radiopharmaceutical therapy with 131I-MIBG or the ALK inhibitor, crizotinib. After enrollment, patients will receive one cycle ...